These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31594689)

  • 1. Predictors of uterine fibroid volume reduction under ulipristal acetate: a prospective MRI study.
    Netter A; Pauly V; Siles P; Pivano A; Vidal V; Agostini A
    Reprod Biomed Online; 2019 Nov; 39(5):795-801. PubMed ID: 31594689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factor for volume reduction of uterine fibroids after short-term use of ulipristal acetate.
    Yun BS; Seong SJ; Jung YW; Kim ML; Bae HS; Kim MK; Shim SS
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():133-136. PubMed ID: 29602142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of ulipristal acetate therapy compared with uterine artery embolization on fibroid volume and vascularity indices assessed by three-dimensional ultrasound: prospective observational study.
    Czuczwar P; Wozniak S; Szkodziak P; Milart P; Wozniakowska E; Wrona W; Paszkowski T
    Ultrasound Obstet Gynecol; 2015 Jun; 45(6):744-50. PubMed ID: 25251811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Ulipristal Acetate Therapy on Uterine Fibroid-Related Symptoms and on Uterine and Fibroid Volumes and Vascularity Indices Assessed by Ultrasound.
    Baggio S; Pomini P; Galeone F; Presti F; Santi L; Raffaelli R; Franchi M
    J Ultrasound Med; 2018 Sep; 37(9):2215-2223. PubMed ID: 29498074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ulipristal acetate for uterine fibroids: 2 years of real world experience in a UK hospital.
    Woodhead N; Pounds R; Irani S; Pradhan P
    J Obstet Gynaecol; 2018 Aug; 38(6):813-817. PubMed ID: 29526144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term intermittent pharmacological therapy with ulipristal acetate on reducing the volume of uterine fibroids and relieving symptoms.
    Kyeong HK; Choi J; Na YJ; Kim HG
    Minerva Obstet Gynecol; 2023 Jun; 75(3):236-242. PubMed ID: 36786781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.
    Barlow DH; Lumsden MA; Fauser BC; Terrill P; Bestel E
    Hum Reprod; 2014 Mar; 29(3):480-9. PubMed ID: 24457604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in fibroid vascularity after three months of pre-treatment with leuprolide acetate or ulipristal acetate: A pilot study.
    Frijlingh M; De Milliano I; Hehenkamp WJK; Huirne JAF
    Eur J Obstet Gynecol Reprod Biol; 2020 Feb; 245():186-192. PubMed ID: 31679806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment of uterine fibroids with ulipristal acetate ☆.
    Donnez J; Vázquez F; Tomaszewski J; Nouri K; Bouchard P; Fauser BC; Barlow DH; Palacios S; Donnez O; Bestel E; Osterloh I; Loumaye E;
    Fertil Steril; 2014 Jun; 101(6):1565-73.e1-18. PubMed ID: 24630081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect on surgical decisions: Ulipristal acetate as key player in Belgian phase IV registration trial.
    Verguts J; Godin PA; De Vree B; Donnez O; Cosyns S; Luyckx M; Nisolle M
    Int J Gynaecol Obstet; 2019 Dec; 147(3):339-343. PubMed ID: 31502668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ulipristal acetate before in vitro fertilization: efficacy in infertile women with submucous fibroids.
    Morgante G; Centini G; Troìa L; Orvieto R; De Leo V
    Reprod Biol Endocrinol; 2020 May; 18(1):50. PubMed ID: 32430027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of changes in uterine and fibroid volume during treatment of heavy menstrual bleeding (HMB).
    Yin K; Whitaker L; Hojo E; McLenachan S; Walker J; McKillop G; Stubbs C; Priest L; Cruz M; Roberts N; Critchley H
    Hum Reprod Open; 2023; 2023(3):hoad021. PubMed ID: 37304815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of women with uterine fibroids in reproductive center: retrospective analysis of clinical and reproductive outcomes.
    Miriello D; Galanti F; Meneghini C; Fabiani C; Dal Lago A; Schiavi MC; Rago R
    Minerva Obstet Gynecol; 2022 Apr; 74(2):130-136. PubMed ID: 33876897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of patients with uterine fibroids after 3-month ulipristal acetate therapy.
    Brun JL; Rajaonarison J; Froeliger A; Monseau-Thiburce AC; Randriamboavonjy R; Vogler A
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():13-18. PubMed ID: 29328939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selective progesterone receptor modulator (ulipristal acetate--a new option in the pharmacological treatment of uterine fibroids in women].
    Szamatowicz M; Kotarski J
    Ginekol Pol; 2013 Mar; 84(3):219-22. PubMed ID: 23700851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in sexuality during ulipristal acetate treatment in women with symptomatic uterine fibroids.
    Tuschy B; Gabbert M; Weiss C; Hornemann A; Wuhrer A; Sütterlin M; Berlit S
    Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():106-110. PubMed ID: 29920429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ethnicity in treating uterine fibroids with ulipristal acetate.
    Murji A; Crosier R; Chow T; Ye XY; Shirreff L
    Fertil Steril; 2016 Oct; 106(5):1165-1169. PubMed ID: 27336213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ulipristal acetate for uterine fibroid-related symptoms.
    Puchar A; Luton D; Koskas M
    Drugs Today (Barc); 2015 Nov; 51(11):661-7. PubMed ID: 26744741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic drug evaluation of ulipristal acetate for the treatment of uterine fibroids.
    Ferrero S; Vellone VG; Barra F
    Expert Opin Drug Metab Toxicol; 2018 Jan; 14(1):107-116. PubMed ID: 29250979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term medical management of uterine fibroids with ulipristal acetate.
    Donnez J; Donnez O; Matule D; Ahrendt HJ; Hudecek R; Zatik J; Kasilovskiene Z; Dumitrascu MC; Fernandez H; Barlow DH; Bouchard P; Fauser BC; Bestel E; Loumaye E
    Fertil Steril; 2016 Jan; 105(1):165-173.e4. PubMed ID: 26477496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.